Pierre Legault - Dec 20, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role
Director
Signature
/s/ Lee Kalowski, Attorney-in-Fact
Stock symbol
BCYC
Transactions as of
Dec 20, 2021
Transactions value $
-$7,384,203
Form type
4
Date filed
12/22/2021, 08:00 PM
Next filing
Jan 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCYC Ordinary Shares Options Exercise $63.9K +7.6K $8.41 7.6K Dec 20, 2021 Direct F1
transaction BCYC Ordinary Shares Sale -$434K -7.6K -100% $57.02 0 Dec 20, 2021 Direct F2, F3
transaction BCYC Ordinary Shares Options Exercise $376K +44.5K $8.44 44.5K Dec 21, 2021 Direct F4
transaction BCYC Ordinary Shares Sale -$2.54M -44.5K -100% $57.11 0 Dec 21, 2021 Direct F2, F5
transaction BCYC Ordinary Shares Options Exercise $830K +97.9K $8.48 97.9K Dec 22, 2021 Direct F6
transaction BCYC Ordinary Shares Sale -$5.68M -97.9K -100% $58.01 0 Dec 22, 2021 Direct F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCYC Stock Option (Right to Buy) Options Exercise $0 -7.6K -4.39% $0.00 166K Dec 20, 2021 Ordinary Shares 7.6K $8.41 Direct F1, F8
transaction BCYC Stock Option (Right to Buy) Options Exercise $0 -44.5K -26.88% $0.00 121K Dec 21, 2021 Ordinary Shares 44.5K $8.44 Direct F4, F8
transaction BCYC Stock Option (Right to Buy) Options Exercise $0 -97.9K -80.76% $0.00 23.3K Dec 22, 2021 Ordinary Shares 97.9K $8.48 Direct F6, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021.
F2 Shares were sold pursuant to a Rule 10b5-1 trading plan.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5) and (7).
F4 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.55 inclusive.
F6 This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.331495 to GBP 1.00 as of December 22, 2021.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.50 inclusive.
F8 This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022.